McKesson Ventures picks up seasoned healthcare investment strategist

SAN FRANCISCO, Calif. – McKesson Ventures, the venture capital arm of McKesson Corporation, on Tuesday announced that Dave Schulte has been appointed managing director, effective Sept. 8, 2015. Schulte joins McKesson from Kaiser Permanente Ventures where he served as VP and managing director. 

 

In his role at McKesson, Schulte will be responsible for co-leading the development and management of the McKesson Ventures portfolio alongside group leader Tom Rodgers.

 

“Dave is a well-respected, active investor in the areas of health care where we are focused and adding him to the team will help us continue to grow the fund and develop our portfolio,” stated Rodgers, SVP and managing director, McKesson Ventures. “At Kaiser Permanente, he demonstrated how a strategic investor can optimize its partnership with early stage companies to build value for both sides.”

 

McKesson Ventures, established in December 2014, has made minority investments in Carena, a telemedicine provider; Accolade, a concierge health care navigation and employee health engagement platform; PipelineRx, a technology and services platform company focused on telepharmacy, and Rock Health’s seed fund, among others. The fund targets companies that are both enabling and benefitting from disruptive changes affecting the health care industry, including increasing consumerism, emergence of alternate delivery models and the shift towards value based care.

 

Schulte has more than 17 years of experience as an investor and investment banker, partnering with entrepreneurs to grow innovative health care and technology businesses. He joined Kaiser Permanente Ventures in 2003 and helped build the investment program from $20 million to $400 million of assets under management. Schulte led Kaiser Permanente Ventures’ investment team, whose IT and Digital Health investments include: Ginger.io, Health Catalyst, Ingenious Med, KitCheck, MetricStream, Omada Health, Proteus Digital Health, Validic and Rock Health’s seed fund.

 

Prior to KP Ventures, Schulte was a software and health care investment banker at J.P. Morgan, UBS and Piper Jaffray. He is a graduate of St. John's University and earned a Master of Public Policy degree from Harvard University.